Correction: The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer

Title:	Correction: The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer
Authors:	Constantin, TA Varela-Carver, A Greenland, KK De Almeida, GS Olden, E Penfold, L Ang, S Ormrod, A Leach, DA Lai, C-F Ainscow, EK Bahl, AK Carling, D Fuchter, MJ Ali, S Bevan, CL
Item Type:	Journal Article
Issue Date:	23-Mar-2024
Date of Acceptance:	1-Feb-2024
URI:	http://hdl.handle.net/10044/1/111621
DOI:	10.1038/s41416-024-02606-w
ISSN:	0007-0920
Publisher:	Springer Nature [academic journals on nature.com]
Start Page:	892
End Page:	892
Journal / Book Title:	British Journal of Cancer
Volume:	130
Issue:	5
Copyright Statement:	© The Author(s) 2024 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Publication Status:	Published
Conference Place:	England
Online Publication Date:	2024-02-14
Appears in Collections:	Department of Surgery and Cancer Chemistry Institute of Clinical Sciences Faculty of Medicine Faculty of Natural Sciences

This item is licensed under a Creative Commons License